Concord Medical Services Hldg Ltd (NYSE:CCM) has been given a consensus broker rating score of 3.70 (Sell) from the one brokers that cover the stock, Zacks Investment Research reports. One equities research analyst has rated the stock with a sell recommendation.
Brokers have set a 1 year consensus price objective of $2.00 for the company and are expecting that the company will post ($0.03) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Concord Medical Services an industry rank of 99 out of 256 based on the ratings given to its competitors.
Separately, Zacks Investment Research raised DLH from a “sell” rating to a “hold” rating in a research note on Tuesday.
CCM stock traded down $0.01 on Friday, reaching $2.61. The company had a trading volume of 57,193 shares, compared to its average volume of 25,090. Concord Medical Services has a 1 year low of $1.85 and a 1 year high of $4.19. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.90. The firm’s fifty day moving average price is $2.36. The company has a market capitalization of $113.61 million, a P/E ratio of -2.18 and a beta of -0.19.
Concord Medical Services Company Profile
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
Featured Story: How Do Mutual Funds Work?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.